Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Given Imaging predicts 2006 launch for third-generation PillCam SB:

This article was originally published in Clinica

Executive Summary

Given Imaging is developing a third-generation version of its ingestable video capsule, PillCam SB, for imaging the small bowel. The modified device, which is being developed in collaboration with Boise, Idaho-based Micron Technology and Ottawa, Canada firm Zarlink Semiconductor, is expected to become commercially available in 2006. It features an improved frame rate of four frames per second - the previous model's rate was two frames per second - and an increased operational time of nine hours - up from eight hours. PillCam SB is used for the direct visualisation of the small intestine and is approved for sale in more than 50 countries worldwide. Yoqneam, Israel-based Given said it is also conducting clinical trials of its PillCam COLON device.

You may also be interested in...



Butterfly Network’s CEO Sees Blank Check Deal As Path To ‘Democratize’ Portable Imaging Platform

Butterfly Network chose SPAC route with Longview Acquisition Corp. to scale its business and expand into the home market in 2021.

Regenerative Medicine Comes Of Age – In The Age Of COVID-19

Regulatory review resource-intensive cell and gene therapy licensing applications are rolling toward US FDA along expedited pathways, while complete response letters and missed goal dates start to stack up under pandemic inspection constraints.

With Warp Speed Decisions Already Made, Transitioning To Biden Admin Should Be No Trouble, Slaoui Says

As vaccines near availability, Moncef Slaoui says his full-time role at OWS may be ending. He has not met with the Biden Transition team, but notes that other Warp Speed officials have.

Topics

UsernamePublicRestriction

Register

OM004559

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel